Concepedia

David Rysanek

DR

3

Publications

77

Citations

3

H-Index

2022

Active since

Affiliations

Czech Academy of Sciences, Institute of Molecular Genetics(Current)

University of Hradec Králové

David Rysanek is an author at Czech Academy of Sciences, Institute of Molecular Genetics specializing in medicine, tumor biology, and cell signaling.

ORCID

Top concepts

Publications per year

2022–2023

3

Publications

3

Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells

David Rysanek, Pavla Vašicová, Jayaprakash Narayana Kolla et al. · Aging · 2022 · 37 citations · Full text

, , +17

STAT3 inhibitor Stattic and its analogues inhibit STAT3 phosphorylation and modulate cytokine secretion in senescent tumour cells

Romana Mikyšková, Olena Sapeg, Miroslav Psotka et al. · Molecular Medicine Reports · 2023 · 23 citations · Full text

, , +23

Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics

Žofia Chrienová, David Rysanek, Patrik Olekšák et al. · Frontiers in Aging Neuroscience · 2022 · 17 citations · Full text

Rows per page

1–3 of 3